HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takeshi Nakano Selected Research

Todralazine

2/2007A novel mechanism for drug-induced liver failure: inhibition of histone acetylation by hydralazine derivatives.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takeshi Nakano Research Topics

Disease

36Hepatocellular Carcinoma (Hepatoma)
08/2006 - 01/2002
28Neoplasms (Cancer)
01/2012 - 02/2002
11Pulmonary Embolism
01/2009 - 12/2002
7Fibrosis (Cirrhosis)
03/2008 - 03/2002
6Myocardial Infarction
01/2008 - 07/2002
6Infections
12/2005 - 08/2002
6Venous Thrombosis (Deep-Vein Thrombosis)
08/2005 - 12/2002
6Liver Cirrhosis (Hepatic Cirrhosis)
03/2005 - 07/2002
5Chronic Hepatitis C
12/2005 - 09/2002
5Heart Failure
10/2005 - 04/2003
5Tachycardia (Tachyarrhythmias)
04/2005 - 02/2002
4Hepatitis
11/2005 - 09/2002
4Adenocarcinoma
10/2005 - 05/2002
4Hemorrhage
11/2003 - 07/2002
3Thrombosis (Thrombus)
12/2010 - 03/2003
3Stroke (Strokes)
01/2008 - 03/2003
3Liver Diseases (Liver Disease)
12/2005 - 08/2004
3Varicose Veins (Varicose Vein)
11/2003 - 07/2002
3Esophageal and Gastric Varices (Esophageal Varices)
11/2003 - 07/2002
2Prostatic Neoplasms (Prostate Cancer)
10/2017 - 04/2016
2Pulmonary Arterial Hypertension
01/2013 - 02/2006
2Disorders of Excessive Somnolence (Hypersomnia)
08/2011 - 08/2003
2Shock
01/2009 - 03/2005
2Hepatitis C
12/2006 - 04/2005
2Virus Diseases (Viral Diseases)
10/2005 - 10/2005
2Autoimmune Diseases (Autoimmune Disease)
10/2005 - 09/2002
2Hemangioma (Angioma)
10/2005 - 02/2003
2Hypertension (High Blood Pressure)
10/2005 - 03/2003
2Necrosis
10/2005 - 02/2002
2Disseminated Intravascular Coagulation
01/2005 - 11/2002
2Myocardial Ischemia (Ischemic Heart Diseases)
10/2003 - 07/2002
2Abscess
11/2002 - 04/2002
2Liver Abscess
11/2002 - 04/2002
1Tardive Dyskinesia
01/2021
1Dyskinesias (Dyskinesia)
01/2021
1Schizophrenia (Dementia Praecox)
01/2021
1Cardiac Tamponade
11/2018
1Myoclonus (Nocturnal Myoclonus)
01/2018
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
01/2018
1Gaucher Disease (Gaucher's Disease)
01/2018

Drug/Important Bio-Agent (IBA)

7InterferonsIBA
12/2005 - 08/2002
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2005 - 01/2002
5rho-Associated KinasesIBA
01/2013 - 03/2003
5NF-kappa B (NF-kB)IBA
10/2005 - 09/2002
5Contrast MediaIBA
10/2005 - 07/2002
5LigandsIBA
10/2005 - 05/2002
5SHU 508 (Levovist)IBA
10/2005 - 07/2002
5Proteins (Proteins, Gene)FDA Link
01/2005 - 07/2003
4Pharmaceutical PreparationsIBA
02/2007 - 09/2003
4TNF-Related Apoptosis-Inducing LigandIBA
08/2006 - 05/2002
4Ethanol (Ethyl Alcohol)IBA
11/2003 - 02/2002
3SteroidsIBA
10/2017 - 08/2011
3Death Domain ReceptorsIBA
08/2006 - 07/2003
3Hepatitis B e AntigensIBA
11/2005 - 08/2002
3AntibodiesIBA
10/2005 - 08/2004
3Angiotensin Receptor AntagonistsIBA
12/2004 - 04/2003
3PPAR gammaIBA
12/2003 - 01/2002
3Tumor Biomarkers (Tumor Markers)IBA
11/2003 - 03/2002
3Anti-Bacterial Agents (Antibiotics)IBA
09/2003 - 03/2002
2Hormones (Hormone)IBA
10/2017 - 08/2008
2OrexinsIBA
08/2011 - 08/2003
2Caspase 8 (Caspase-8)IBA
08/2006 - 07/2003
2Caspase InhibitorsIBA
03/2006 - 01/2002
2X-Linked Inhibitor of Apoptosis ProteinIBA
11/2005 - 08/2004
2SurvivinIBA
11/2005 - 09/2002
2TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
10/2005 - 08/2004
2fibrin fragment D (D-dimer)IBA
08/2005 - 01/2005
2FibrinIBA
08/2005 - 01/2005
2CytokinesIBA
05/2005 - 09/2002
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2005 - 03/2003
2Interleukin-18 (Interleukin 18)IBA
05/2005 - 03/2005
2Fluorouracil (Carac)FDA LinkGeneric
03/2005 - 03/2003
2Cisplatin (Platino)FDA LinkGeneric
03/2005 - 03/2003
2AntigensIBA
01/2005 - 01/2005
2Dacarbazine (DIC)FDA LinkGeneric
01/2005 - 11/2002
2Messenger RNA (mRNA)IBA
01/2005 - 01/2005
2CamptothecinIBA
01/2005 - 09/2002
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
12/2004 - 04/2003
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
12/2004 - 04/2003
2Epirubicin (Ellence)FDA LinkGeneric
07/2004 - 03/2003
2Prednisolone (Predate)FDA LinkGeneric
07/2004 - 08/2003
2DobutamineFDA LinkGeneric
01/2004 - 01/2003
2acarboxyprothrombin (PIVKA)IBA
10/2003 - 03/2002
2DNA (Deoxyribonucleic Acid)IBA
09/2002 - 04/2002
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
03/2002 - 02/2002
1Antipsychotic Agents (Antipsychotics)IBA
01/2021
1blonanserinIBA
01/2021
1TabletsIBA
01/2021
1Glucosylceramidase (Glucocerebrosidase)IBA
01/2018
1Glucosylceramides (Glucocerebrosides)IBA
01/2018

Therapy/Procedure

20Therapeutics
08/2011 - 02/2002
4Catheters
01/2009 - 02/2002
3Vena Cava Filters (Inferior Vena Cava Filter)
11/2018 - 12/2002
3Radiofrequency Ablation
04/2005 - 12/2002
3Drug Therapy (Chemotherapy)
03/2005 - 03/2003
3Sclerotherapy
09/2003 - 07/2002
2Percutaneous Coronary Intervention
09/2006 - 01/2003
2Thrombolytic Therapy
03/2005 - 03/2005
2Catheter Ablation
01/2005 - 02/2002
1Enzyme Replacement Therapy
01/2018